Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024


Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook.

To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.

A replay will be available on Cerus' website and will be available approximately three hours after the call through May 23, 2024.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.


These press releases may also interest you

at 14:08
Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration...

at 14:07
Concept Systems Launches Innovative New Software to Streamline Automation
Concept Systems, a pioneer in creating automation systems for manufacturers, announced the launch of its newest innovation, evriiRobot. Backed by 20-plus years of integration experience, evriiRobot allows for the dynamic configuration of automation...

at 14:06
HITRUST Enhances Cyber Threat Adaptive Engine Using Microsoft Azure OpenAI Service and Microsoft Defender Threat Intelligence
HITRUST, a leader in information security, risk, and compliance assurance, today announced a comprehensive update to its Cyber Threat Adaptive engine to enable increased accuracy and timeliness of HITRUST CSF updates to address emerging cyber...

at 14:05
CACI to Participate in Bank of America Securities 31st Annual Transportation, Airlines and Industrials Conference
CACI International Inc , a leading provider of distinctive expertise and differentiated technology to U.S. government customers in support of critical national security missions and government modernization, announced today that the company will...

at 14:05
Xtract One Closes Full Exercise of Over-Allotment Option for Additional $1.2 M
Xtract One Technologies Inc. (FRA: 0PL) ("Xtract One" or the "Company") announces that, in connection with its previously announced public offering (the "Offering"), Eight Capital, as lead agent and sole bookrunner, and Echelon Wealth Partners...

at 14:05
BANDIT WINES INTRODUCES 'GO EXPLORE NATIONAL PARKS' INNOVATIVE AUGMENTED-REALITY WINE PACKAGING
Bandit Wines, a wine brand synonymous with adventure, today unveiled an Augmented Reality (AR) platform featuring a 360-degree video portal, an innovative step in consumer engagement. Developed by global production studio Aircards, and powered by...

More news about Science and technology...


News published on and distributed by: